Global Hematology Oncology Market, By Hematology Product (Hematology Analyzers, Hematology Reagents, Flow Cytometers, Hematology Cell Counters, Slide Strainers, Coagulation Analyzers, Hematology Testing, Centrifuges, Hemoglobin meters, Others), By Oncology Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy), By Oncology Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Others), By Applications (Infectious Diseases, Cancer, Cardiovascular Disorders, Blood Screening, Diabetes, HIV, Auto – Immune Diseases), By End Users (Hospitals, Clinical Testing Institutes, Patient Self- Testing, Other End- Users) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI481921 | Publish Date: May 2023 | No. of Pages: 155

Global Hematology Oncology Market Overview

Hematology is the study of blood and bone marrow illnesses, as well as their diagnosis, prevention, and therapy. Oncology is the branch of medicine that deals with the prevention, treatment, and diagnosis of cancer. Hematology is used in a variety of settings, including cardiovascular disease, diabetes, cancer, and blood screening. Medical, surgical, and radiation oncology are the three main areas where oncology is used. Hemato oncology testing examines blood abnormalities in the medical sector, such as iron deficiency anaemia, haemophilia, sickle cell disease, leukemias, lymphomas, and malignancies of various organs. Hematologists and oncologists commonly collaborate to treat serious diseases such as leukaemia and lymphoma, and haematologists and oncologists often work together to treat these diseases. The entire hemato oncology testing will be reliable and successful as a result of technological advancements and accurate information use. Hematological oncology play an important role in the detection and treatment of cancers of the bone marrow, blood, and lymph nodes. The COVID-19 pandemic has disrupted the most critical parts of the oncology pharmaceuticals business by disrupting clinical studies and drug delivery to patients. The pandemic has had a direct impact on cancer patients' access to oncology drugs; not only is it difficult to administer chemotherapy and other treatments outside of a clinic, but the spread of coronavirus has reduced patients' willingness and ability to access not only treatments, but also clinical trials for new medicines. The Global Hematology Oncology Market accounted for US$ 2.21 billion in 2020 and is estimated to be US$ 6.57 billion by 2030 and is anticipated to register a CAGR of 11.5%.

Global Hematology Oncology Market Dynamics

Rising prevalence of lymphoma and myeloma will drive the growth of the Market

One of the primary factors driving the growth of the haematology oncology market is the rising prevalence of lymphoma and myeloma around the world. The rise in the availability of improved molecular techniques for the diagnosis of hemato oncology, as well as the proliferation of sequencing techniques such as NGS due to the rise in cost of development and sequencing of the Human Genome Project in the field of genomics, are driving market expansion. The advent of sophisticated molecular techniques in addressing issues about blood cancer prognosis, treatment course, and diagnosis, as well as an increase in the number of instances of blood disorders, are all factors that have an impact on the market. Furthermore, attractive reimbursement procedures, pharmaceutical company partnership, and an increase in healthcare expenditure all benefit the haematological oncology industry. Furthermore, in the projected period of 2021 to 2028, a surge in the co-development of the drug-diagnostics model would provide profitable opportunities to market players.

Increased cancer prevalence and incidence of various cancer disorders, as well as increased popularity of advanced therapies (biological and targeted medication therapies) and an increase in the global elderly population. Furthermore, increased cancer awareness and early cancer screening contribute to the growth of the oncology medications industry. However, the high costs associated with new medication development, as well as the risk of failure and side effects associated with cancer treatment therapies, are limiting the market's expansion. Conversely, during the projected period, the high potential of rising economies and the greater number of prospective medications in the pipeline are expected to provide profitable prospects.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Hematology Oncology Market Segmentation

 

                                                          Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The Global Hematology Oncology Market is segmented based on Hematology Product, Oncology Drug Class, Oncology Indication, Application, End-User and region.

On the basis of Hematology Product, the Global Hematology Oncology Market is segmented into Hematology Analyzers, Hematology Reagents, Flow Cytometers, Hematology Cell Counters, Slide Strainers, Coagulation Analyzers, Hematology Testing, Centrifuges, Hemoglobin meters, Others. Based on Oncology Drug Class, the target market is segmented into Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy. Based on Oncology Indication, the target market is segmented into Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Others. Based on Application, the target market is segmented into Infectious Diseases, Cancer, Cardiovascular Disorders, Blood Screening, Diabetes, HIV, Auto – Immune Diseases. Based on End-User, the target market is segmented into Hospitals, Clinical Testing Institutes, Patient Self- Testing, Other End- Users.

Regional Insights:

 

                                                                                                                                        Source: Prophecy Market Insights

                                         

On region the Global Hematology Oncology Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Due to the rising frequency of leukaemia, lymphoma, and multiple myeloma in the region, North America dominates the haematology oncology industry. Due to the expanding number of research activities done by various academic research institutes in the region, Asia-Pacific is predicted to have considerable increase over the forecast period of 2021 to 2030.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Hematology Product- Hematology Analyzers, Hematology Reagents, Flow Cytometers, Hematology Cell Counters, Slide Strainers, Coagulation Analyzers, Hematology Testing, Centrifuges, Hemoglobin meters, Others

By Oncology Drug Class– Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy

By Oncology Indication- Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Others

By Application- Infectious Diseases, Cancer, Cardiovascular Disorders, Blood Screening, Diabetes, HIV, Auto – Immune Diseases

By End-Users- Hospitals, Clinical Testing Institutes, Patient Self- Testing, Other End- Users

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Hematology Oncology Market report based on Hematology Product, Oncology Drug Class, Oncology Indication, Application, End-User and region.

Global Hematology Oncology Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Hematology Oncology Market Key Players

The key players operating in the hematology oncology market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Danaher, Thermo Fisher Scientific Inc., AbbVie Inc., Astellas Pharma Inc., AstraZeneca, Bristol-Myers Squibb Company, CELGENE CORPORATION, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., Boule, Sysmex Corporation, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd, Novo Nordisk A/S, and PerkinElmer Inc., among other domestic and global players.

Global Hematology Oncology Market Company Profile

  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Danaher
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Astellas Pharma Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bristol-Myers Squibb Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Global Hematology Oncology Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Hematology Oncology Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Hematology Product
      • Market Snippet, By Oncology Drug Class
      • Market Snippet, By Oncology Indication
      • Market Snippet, By Application
      • Market Snippet, By End-User
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Hematology Oncology Market, By Hematology Product, 2020 – 2030, (US$ Bn)
    • Overview                                                                                     
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hematology Analyzers
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Hematology Reagents
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Flow Cytometers
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Hematology Cell Counters
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Slide Strainers
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Coagulation Analyzers
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Hematology Testing
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Centrifuges
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Hemoglobin Meter
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Hematology Oncology Market, By Oncology Drug Class, 2020 – 2030, (US$ Bn)
    • Overview                                                
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Chemotherapy
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Targeted Therapy
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Immunotherapy
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Hormonal Therapy
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Hematology Oncology Market, By Oncology Indications, 2020 – 2030, (US$ Bn)
    • Overview                                   
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Lung Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Stomach Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Colorectal Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Breast Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Prostate Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Liver Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Esophagus Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Cervical Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Kidney Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Bladder Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Hematology Oncology Market, By Application, 2020 – 2030, (US$ Bn)
    • Overview                                                                   
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Infectious Diseases
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Cardiovascular Disorders
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Blood Screening
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Diabetes
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • HIV
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Auto-Immune Diseases
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  9. Global Hematology Oncology Market, By End-User, 2020 – 2030, (US$ Bn)
    • Overview                                                                   
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospitals
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Clinical Testing Institutes
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Patient Self Testing
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  10. Global Hematology Oncology Market, By Region, 2020 – 2030, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Hematology Product, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Oncology Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Oncology Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Hematology Product, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Oncology Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Oncology Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Hematology Product, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Oncology Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Oncology Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Hematology Product, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Oncology Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Oncology Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Bn), By Hematology Product, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Oncology Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Oncology Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  11. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  12. Company Profiles
  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Danaher
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Astellas Pharma Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bristol-Myers Squibb Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

Global Hematology Oncology Market is segmented based on Hematology Product, Oncology Drug Class, Oncology Indication, Application, End-User and region.

Rising prevalence of lymphoma and myeloma is major factor driving the market.

During the forecast period, North America is expected to dominate the market.

The key players operating in the hematology oncology market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Danaher, Thermo Fisher Scientific Inc., AbbVie Inc., Astellas Pharma Inc., AstraZeneca, Bristol-Myers Squibb Company, CELGENE CORPORATION, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., Boule, Sysmex Corporation, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd, Novo Nordisk A/S, and PerkinElmer Inc., among other domestic and global players